# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-26-007962
Filing Date
2026-03-12
Accepted
2026-03-12 16:01:42
Documents
87
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | sava20251231_10k.htm iXBRL | 10-K | 1797297
2 | EXHIBIT 4.2 | ex_895112.htm | EX-4.2 | 45273
3 | EXHIBIT 10.11 | ex_916607.htm | EX-10.11 | 274275
4 | EXHIBIT 19.1 | ex_895114.htm | EX-19.1 | 33763
5 | EXHIBIT 21.1 | ex_895115.htm | EX-21.1 | 3651
6 | EXHIBIT 23.1 | ex_895116.htm | EX-23.1 | 6800
7 | EXHIBIT 31.1 | ex_895117.htm | EX-31.1 | 12504
8 | EXHIBIT 31.2 | ex_895118.htm | EX-31.2 | 12488
9 | EXHIBIT 32.1 | ex_895119.htm | EX-32.1 | 5077
10 | EXHIBIT 97 | ex_895120.htm | EX-97 | 25574
16 |  | filana.jpg | GRAPHIC | 8842
| Complete submission text file | 0001437749-26-007962.txt |  | 8390443

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | flna-20251231.xsd | EX-101.SCH | 67122
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | flna-20251231_cal.xml | EX-101.CAL | 56383
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | flna-20251231_def.xml | EX-101.DEF | 436584
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | flna-20251231_lab.xml | EX-101.LAB | 414437
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | flna-20251231_pre.xml | EX-101.PRE | 479157
90 | EXTRACTED XBRL INSTANCE DOCUMENT | sava20251231_10k_htm.xml | XML | 1207067

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
FILANA THERAPEUTICS, INC. (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41905 | Film No.: 26747514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)